These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 33663363)
1. Exploration of Potent Multi-target-directed-ligands as Anti-alzheimer's Disease Agents: A Moiety Based Review. Teli P; Sahiba N; Soni J; Sethiya A; Agarwal DK; Agarwal S Mini Rev Med Chem; 2021; 21(20):3219-3248. PubMed ID: 33663363 [TBL] [Abstract][Full Text] [Related]
3. Management of oxidative stress and other pathologies in Alzheimer's disease. Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798 [TBL] [Abstract][Full Text] [Related]
4. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. Li Q; He S; Chen Y; Feng F; Qu W; Sun H Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151 [TBL] [Abstract][Full Text] [Related]
5. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents. George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473 [TBL] [Abstract][Full Text] [Related]
6. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease. Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease. Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225 [TBL] [Abstract][Full Text] [Related]
8. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease. Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693 [TBL] [Abstract][Full Text] [Related]
9. Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease. Hiremathad A; Keri RS; Esteves AR; Cardoso SM; Chaves S; Santos MA Eur J Med Chem; 2018 Mar; 148():255-267. PubMed ID: 29466775 [TBL] [Abstract][Full Text] [Related]
10. Novel Donepezil-Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer's Disease. Queda F; Calò S; Gwizdala K; Magalhães JD; Cardoso SM; Chaves S; Piemontese L; Santos MA Molecules; 2021 Mar; 26(6):. PubMed ID: 33809771 [TBL] [Abstract][Full Text] [Related]
12. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease. García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182 [TBL] [Abstract][Full Text] [Related]
13. New classes of carbazoles as potential multi-functional anti-Alzheimer's agents. Choubdar N; Golshani M; Jalili-Baleh L; Nadri H; Küçükkilinç TT; Ayazgök B; Moradi A; Moghadam FH; Abdolahi Z; Ameri A; Salehian F; Foroumadi A; Khoobi M Bioorg Chem; 2019 Oct; 91():103164. PubMed ID: 31398601 [TBL] [Abstract][Full Text] [Related]
14. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease. Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034 [TBL] [Abstract][Full Text] [Related]
15. Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach. Kumar S; Mahajan A; Ambatwar R; Khatik GL Curr Med Chem; 2024; 31(37):6032-6062. PubMed ID: 37861025 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and molecular modeling simulations of new heterocyclic hybrids as multi-targeted anti-Alzheimer's agents. Waly OM; Saad KM; El-Subbagh HI; Bayomi SM; Ghaly MA Eur J Med Chem; 2022 Mar; 231():114152. PubMed ID: 35101650 [TBL] [Abstract][Full Text] [Related]
17. Tryptamine: A privileged scaffold for the management of Alzheimer's disease. Singh YP; Kumar H Drug Dev Res; 2023 Dec; 84(8):1578-1594. PubMed ID: 37675624 [TBL] [Abstract][Full Text] [Related]
18. Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018). Mishra P; Kumar A; Panda G Bioorg Med Chem; 2019 Mar; 27(6):895-930. PubMed ID: 30744931 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease. Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831 [TBL] [Abstract][Full Text] [Related]